Search Results

1 - 10 of 34 items :

  • Surgery, other x
Clear All
Stem Cell Therapy in Wound Healing

REFERENCES 1. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet . 2005;366:1719-1724. 2. Rando TA. Stem cells, ageing and the quest for immortality. Nature . 2006;441:1080-1086. 3. Sen CK, Gordillo GM, Roy S, et al. Human skin wounds: a major and snowballing threat to public health and the economy. Wound Repair Regen . 2009;17:763-771. 4. Crovetti G, Martinelli G, Issi M, et al. Platelet gel for healing cutaneous chronic wounds. Transfus Apher Sci . 2004;30:145-151. 5

Open access
The Importance of Positive Immunomagnetic Cell Separation Prior to Autologous Hematopoetic Stem Cell Transplantation for Advanced Stage Lymphomas

References 1. Vonk AL, de Windt TS, Slaper-Cortenbach ICM, Saris DBF. Autologous, allogeneic, induced pluripotent stem cell or a combination stem cell therapy. Stem Cell Res Ther. 2015;6:94. 2. Kimbrel EA, Kouris NA, Yavanian GJ, et al. Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties. Stem Cells Dev. 2014;23:1611-1624. 3. Isolex 300i Trening Manual, Version 2, Nexel Therapeutics Inc. USA, 2001, Section 2 4. McDonald-Hyman C, Turka LA, Blazar BR. Advances

Open access
Stem Cell Therapies in Peripheral Vascular Diseases — Current Status

disease using stem and progenitor cell therapy. J Vasc Surg . 2011;53:445-453. 29. Botham CM, Bennett WL, Cooke JP. Clinical trials of adult stem cell therapy for peripheral artery disease. Methodist Debakey Cardiovasc J . 2013;9:201-205. 30. Hirota K, Semenza GL. Regulation of angiogenesis by hypoxiainducible factor 1. Crit Rev Oncol Hematol . 2006;59:15-26. 31. Voskuil M, van Royen N, Hoefer I, Buschmann I, Schaper W, Piek JJ. Angiogenesis and arteriogenesis; the long road from concept to clinical application. Ned Tijdschr Geneeskd . 2001

Open access
Computed Tomographic Assessment of Coronary Arteries in Patients Undergoing Stem Cell Therapy Following an Acute Myocardial Infarction

REFERENCES 1. Finegold JA, Asaria P, Francis DP. Mortality from ischaemic heart disease by country, region, and age: statistics from World Health Organisation and United Nations. Int J Cardiol . 2013;168:934-945. 2. Lauer MS. Advancing cardiovascular research. Chest. 2012;141:500-505. 3. Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science . 2009;324:98-102. 4. Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature . 2008;451:937-942. 5. Asahara T, Kalka C, Isner JM. Stem cell

Open access
Magnetic Resonance Imaging of Myocardial Function Following Intracoronary and Intramyocardial Stem Cell Injection

clinical trials. J Am Coll Cardiol . 2008;21:956-964. 4. David G, David AB. MRI determination of myocardial viability. Appl Radiol . 2006;35. 5. Frangioni JV, Hajjar RJ. In vivo tracking of stem cells for clinical trials in cardiovascular disease. Circulation . 2004;110:3378-3383. 6. Chen IY, Wu JC. Cardiovascular molecular imaging: focus on clinical translation. Circulation . 2011;123:425-443. 7. Comella K, Griffeth J. Stem Cell Research in the Cardiac Field: Where Are We Now? World Stem Cell Report . 2009. 8. Krishna KA, Krishna KS

Open access
Unrelated Allogeneic Stem Cell Transplantation in a Patient with Chronic Myeloid Leukemia in Blast Crisis

. Karbasian Esfahani M, Morris EL, Dutcher JP, et al. Blastic phase of chronic myelogenous leukemia. Curr Treat Options Oncol . 2006;7:189-199. 6. Pavlu J, Szydlo RM, Goldman JM, Apperley JF. Three decades of transplantation for chronic myeloid leukemia: what have we learned? Blood . 2011;117:755-763. 7. Tunyogi AB, Benedek I, Benedek Lázár E, et al. The results of allogeneic stem cell transplantation in CML – the experience of BMT Unit Tîrgu Mureş. Acta Medica Marisiensis . 2011;57:371-374. 8. Gupta A, Khattry N. Current status of hematopoietic stem

Open access
Post Autologous Stem Cell Transplantation Complication Management in Case of Malignant Lymphoma Patients

REFERENCES 1. Hübel K, de la Rubbia J, Azar N, et al. Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective. Eur J Haematol . 2015;94:12-22. 2. Benekou K, Montoto S. Role of stem cell transplant in lymphoma in the era of new drugs. Curr Opin Oncol . 2017;29:455-459. 3. Chiappella A, Martelli M, Angelucci E, et al. Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04

Open access
The Evolution of Intracardiac Hemodynamics Post Autologous Stem Cell Transplant in a Case of Multiple Myeloma Associated with Severe Tricuspid and Mitral Valve Insufficiency

to the Durie Salmon staging system? A comparison in multiple myeloma patients undergoing autologous transplant. Leukemia . 2009;23:1528-1534. 6. Greipp PR, San Miguel J, Durie BG, et al. International staging system for multiple myeloma. J Clin Oncol . 2005;23:3412-3420. 7. San Miguel JF, Bladé Creixenti J, García-Sanz R. Treatment of multiple myeloma. Haematologica . 1999;84:36-58. 8. Fermand JP, Ravaud P, Chevret S, et al. High-dose therapy and autologous peripheral blood stem cell transplantation in multiple myeloma: up-front or rescue

Open access
ACL Primary Repair with Bone Marrow Stimulation and Growth Factors. A Review of Literature

ligament graft. Knee Surg Sports Traumatol Arthrosc . 2008;16:224-231. 8. Claes S, Verdonk P, Forsyth R, Bellemans J. The “ligamentization” process in anterior cruciate ligament reconstruction: what happens to the human graft? A systematic review of the literature. Am J Sports Med . 2011;39:2476-2483. 9. Rizzello G, Longo UG, Petrillo S, et al. Growth Factors and Stem Cells for the Management of Anterior Cruciate Ligament Tears. Open Orthop J . 2012;6:525-530. 10. Bissell L, Tibrewal S, Sahni V, Khan WS. Growth factors and platelet rich plasma in

Open access
Stem Cell Mobilization and Harvesting Failure in Case of Heavily Pretreated Patients

REFERENCES 1. Korbling M, Anderlini P. Peripheral blood stem cell versus bone marrow allotransplantation: does the source of hematopoietic stem cell matter? Blood . 2001;98:2900-2908. 2. To LB, Haylock DN, Simmons PJ, Juttner CA. The biology and clinical uses of blood stem cells. Blood . 1997; 89:2233-2258. 3. Jillella AP, Ustun C. What is the optimum number of CD34 peripheral blood stem cells for an autologous transplant? Stem Cells Dev . 2004;13:598-606. 4. Vose JM, Ho AD, Coiffier B, et al. Advances in mobilization for the

Open access